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Abstract One of the key challenges in the field of
nanoparticle (NP) analysis is in producing reliable and
reproducible characterisation data for nanomaterials.
This study looks at the reproducibility using a
relatively new, but rapidly adopted, technique, Nano-
particle Tracking Analysis (NTA) on a range of
particle sizes and materials in several different media.
It describes the protocol development and presents
both the data and analysis of results obtained from 12
laboratories, mostly based in Europe, who are
primarily QualityNano members. QualityNano is an
EU FP7 funded Research Infrastructure that integrates
28 European analytical and experimental facilities in
nanotechnology, medicine and natural sciences with
the goal of developing and implementing best practice
and quality in all aspects of nanosafety assessment.
This study looks at both the development of the
protocol and how this leads to highly reproducible
results amongst participants. In this study, the param-
eter being measured is the modal particle size.
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Introduction
Nanotechnology is rapidly developing new applica-
tions and advanced materials into many manufactur-
ing areas from information technology, energy storage
and harvesting, to radically new medical technologies.
The projected market figure for nanotechnology
incorporated in manufactured goods by 2020 is
approximately 3,000 billion US dollars worldwide
(Roco 2011). Such exponential global growth is,
however, calling for responsible and quantitative
evaluation of the development of manufacturing
nanomaterials and its associated metrology. This is
particularly true since nanomaterials have unique
physical and chemical properties that are useful for
various consumer and industrial applications, but
these very same properties may give rise to unique
biological reactivity. This has led to mounting
concerns over the safety of nanomaterials and pressure
to control the potential risks (Schrurs and Lison 2012).
To ensure compliance with environmental protection
guidelines (OECD 2009) nanoparticles (NPs) pro-
duced, either directly or indirectly, must be fully
characterised (Hassello¨v et al. 2008; Tiede et al.
2009). This is fundamental in all areas of research and
industry.
Among the different properties which need full
characterisation, the size of NPs and the quality and
stability of their dispersion often have a profound
effect on their interactions with organisms and the
environment. It has been extensively reported that NP
response to the surrounding environment is size
dependent (Jiang et al. 2008; Tenzer et al. 2011) due
to their large surface area that interacts with their
surrounding matrix, and this can influence their
reactivity with toxicity targets in the cells (Lison and
Huaux 2011; Tsao et al. 2011). This has been found to
be particularly relevant when the NPs are used for
targeted applications. For instance, gold NPs have
been used in medical application as contrast agents or
nanocarriers (Tong et al. 2009; Kim et al. 2010),
polystyrene NPs are a good model for diagnostics and
environmental applications due to their relatively
well-defined size and low cost (De Jong and Borm
2008; Fritz et al. 1997), silica NPs as drug delivery
carriers due to their size-dependent toxicity (Greish
et al. 2012; Lin and Haynes 2010; Mohamed et al.
2012) and iron oxide nanoparticles (SPIONS) as
therapeutics carriers (Prina-Mello et al. 2013). There-
fore, when working with NPs, it becomes crucially
important to fully characterise the NPs physico-
chemical properties and their interaction with the
surrounding matrix or environment (Montes-Burgos
et al. 2010; Warheit 2008). This is particularly true
when investigating the efficacy and biodistribution of
NPs in vivo where it is extremely difficult to validate
any mechanism of interactions or kinetics from the
biodistribution data without having accurate particle
size distributions (Gaumet et al. 2008). Therefore the
dispersion state of the NPs in solution becomes a main
parameter to be investigated which can be correlated
to particle stability, and subsequent shelf life and
efficacy (Hassello¨v et al. 2008). Thus, the implications
are not only limited to biological applications but also
to environmental and ecological perspectives, as well
as regulatory (Elsaesser and Howard 2012; Hanna
et al. 2013).
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In fact, it has been extensively reported by many
studies that the nature of the media in which the NPs
are dispersed is driving their response and interaction
at a biological level (Lison and Huaux 2011; Schrurs
and Lison 2012). Several reports have defined and
characterised some aspects of this bio–nano interac-
tion through association with the NP physiochemical
properties (Nel et al. 2009); particle size being the
starting aspect for aggregation consideration, forma-
tion of protein coronas (Casals et al. 2010; Cedervall
et al. 2007) and subsequent shielding of targeting
moieties resulting in loss of NP specificity (Salvati
et al. 2013).
Several techniques have been developed for mea-
suring particle size, shape and dispersity from a
suspension of particles; electron microscopy (EM),
dynamic light scattering (DLS), disc centrifugation,
Coulter principle and NTA amongst others. Some of
these are labour intensive and time demanding whereas
others are cost effective and user friendly. The most
frequently used and user friendly NP size character-
isation technique is DLS (Filipe et al. 2010). This
technique measures the fluctuations in scattered light
intensity caused by NPs moving under Brownian
motion (Frisken 2001). However, the analysis is
weighed towards larger particle size, and as a result,
the presence of NP aggregates will bias the particle size
distribution, resulting in inaccurate size determination.
The use of NTA, with a lower concentration detection
limit compared to DLS, analysing NPs on a particle by
particle basis, offers a new method for the visualisation
and characterisation of NPs in suspension.
The QualityNano project is a European Union
Framework Programme 7 funded infrastructure project
for developing best practice and innovation in nanoma-
terial safety testing. One fundamental activity of the
QualityNano project is the establishment of quality
control and quality assurance conditions for nanomate-
rial safety and assessment. As technologies and meth-
odologies develop in this area, and the number of end-
users increases, the validity of the methodologies and
standards needs to be continuously monitored and
updated to the most stringent industrial requirements.
Quality standards can only be achieved by enlarging
statistical numbering and introducing multivariate ana-
lysis. This can be achieved by adopting a systematic
approach to parametrically assess the interlaboratory,
inter-batches and multi-users variation. NTA has only
been commercialised since 2006 (Filipe et al. 2010) but
the technique has, in recent years, grown rapidly in its
adoption and use, with over 600 systems and 800 third
party papers, consolidating the technique across many
areas of application, such as therapeutic NP character-
isation, developing solutions for diagnostics (e.g.,
exosomes), drug delivery and cancer treatment, devel-
opment of bioanalytical assays, vaccine characterisation
and nanotoxicology. Therefore the adoption of an
interlaboratory comparison (ILC) to validate the NTA
technique, by assessment of panels of nanomaterials
from within the QualityNano project, derives from the
extensive knowledge accumulated and shared between
the QualityNano partners and NanoSight Ltd., Ames-
bury, UK, the company that manufactures the NTA
systems. NTA performance is therefore assessed by a
structured ILC using defined samples measured by
multiple laboratories in order to ascertain the compe-
tence of the laboratory, the quality of the standard
operating procedures (SOPs) and the reproducibility of
the technique. Furthermore, through the use of defined
protocols for measurement of standardised samples, the
ability of the different NTA systems under evaluation to
produce reliable and reproducible results can be inves-
tigated (multi-user’s variation). It is therefore important
to highlight that the uncertainty in the validity and
consistency of results could have important implications
for the determination of the effects of NPs since
different results could be generated when applying
different starting dispersions, thus confusing the out-
comes. During NP characterisation, using best practice
in-house developed SOPs does not always guarantee
consistency with other laboratories, as previously shown
in Roebben’s study for the DLS technique (Roebben
et al. 2011). The recommendation for adopting an ILC
study is therefore ideal for both developing and testing
protocols, as demonstrated in the study presented here,
which has been strongly supported within the Quality-
Nano consortium by NanoSight. The authors in this
manuscript adopted the ILC principles for assessment
from Roebben and coworkers and transferred this to the
NTA technique. For instance, this study adopted the use
of National Institute of Standards and Technology
(NIST) traceable NPs and the supply and modification
of protocols following each analysis round. Reproduc-
ibility analysis was carried out using classical statistical
analysis based around the arithmetic mean values using
the ISO 5725-2 approach (ISO 1994) and robust
statistical analysis centred around methods described
in ISO 5725-5 (ISO 1998). The ILC was also assessed in
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its inter-batch and multi-users variation carried out over
four rounds using blind samples and well-defined SOPs
to produce a protocol for NP size characterisation using
NTA in order to reinforce the robustness of the NTA
technique, its standardisation and effort towards defin-
ing regulatory guidelines.
NTA: technique principle and details
NTA utilises the properties of both light scattering and
Brownian motion in order to obtain particle size
distributions of samples in liquid suspension. A laser
beam (of arbitrary wavelength but typically those
available from laser diodes operating at 635, 532, 488,
or 405 nm) is passed through a prism-edged glass flat
within the sample chamber. The angle of incidence and
refractive index of the glass flat are designed to be such
that when the laser reaches the interface between the
glass and the liquid sample layer above it the beam
refracts, resulting in a compressed beam with a reduced
profile and high power density. The particles in
suspension in the path of this beam scatter light in such
a manner that they can be easily visualised via a long
working distance, 209 magnification microscope objec-
tive, fitted to an otherwise conventional optical micro-
scope. Onto this is mounted either a charged coupled
device (CCD), electron multiplied charged coupled
device (EMCCD) or high-sensitivity complementary
metal–oxide–semiconductor (CMOS) camera, operat-
ing at approximately 30 frames per second (fps), which
captures a video file of the light scattered by particles
moving under Brownian motion, within a field of view
of approximately 100 lm 9 80 lm 9 10 lm (Fig. 1).
Within the field of view, particles are seen moving
under Brownian motion, either directly by eye using the
microscope oculars or via the camera. The proprietary
NTA software records a video file (of typically 30–60 s
duration) of the particles viewed and then simulta-
neously identifies and tracks the centre of each particle
on a frame-by-frame basis. The image analysis software
then determines the average distance moved by each
particle in the x and y directions. This value allows the
particle diffusion coefficient (Dt) to be determined, from
which, if the sample temperature (T) and solvent
viscosity (g) are known, then the sphere-equivalent
hydrodynamic diameter (d) of the particles can be
identified using the Stokes–Einstein equation (Eq. 1).
Dt ¼ TKB
3pgd
ð1Þ
where KB is Boltzmann’s Constant.
Brownian motion occurs in three dimensions but
NTA observes motion only in two dimensions.
However, the fact that three-dimensional Brownian
motion is tracked only in two dimensions is accounted
for by the use of the following variation of the Stokes–
Einstein equation (Eq. 2). It is possible, however, to
determine Dt from measuring the mean squared
displacement of a particle in one, two or three
dimensions (Eq. 2, respectively).
ðx2Þ ¼ 2TKBt
3Pgd
a
ðx; yÞ2 ¼ 4TKBt
3Pgd
b
ðx; y; zÞ2 ¼ 2TKBt
Pgd
c
ð2Þ
Thus, in the case where measurement of movement
in two dimensions is made; Eq. 2b is employed.
One crucial advantage that NTA has over other
measurement techniques is that it is not biased towards
larger particles or aggregates. The software is based on
the tracking of single particles, whereas typical DLS
techniques place a strong bias on the largest particles
present in the sample (Filipe et al. 2010). NTA
therefore allows for the detection of secondary peaks,
which may not be detectable or resolvable using other
traditional measurements.
NTA: standardisation
Early steps towards standardisation of NTA have
recently been demonstrated by an ASTM guidance
Fig. 1 Schematic of the optical configuration used in NTA
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paper published about the technique (ASTM 2012)
providing an overview of the methodology to be
followed for good practice and discussing aspects such
as principles and limitations of the method, consider-
ations of sampling, necessary concentration and
interpretation of results, with particular reference to
comparison with other techniques. An International
Standardisation Community at ISO TC24 welcomed
the submission of a new work item proposal on
Particle Tracking Analysis (PTA)/NTA at their recent
meeting (ISO 2013).
Standardisation of the NTA technique has previ-
ously been difficult to achieve due to the number of
software options that a user has been required to choose
in order to make a measurement. This was highlighted
in an excellent paper comparing DLS and NTA (Filipe
et al. 2010) which highlighted this issue of subjectivity
of NTA results with user settings. Table 1 summarises
the development of the software since that point,
showing the progression of algorithm development
allowing these settings to be effectively automated.
The ILC assessment design in this study employs
the NTA2.3 software version which had three settings
that users should set. These were: (1) capture time
(unified for all laboratories and users by supplied
SOP), (2) camera level and (3) detection threshold
(guidance provided for 2 and 3 by the supplied SOP).
NTA: regulatory aspect
It is expected that the outcomes of ILC studies of the
NTA technique could contribute to the defining of
regulatory policy and guidelines for the adoption of
safe nanotechnology procedures in line with the goals
of QualityNano, through the generation of SOPs for
the accurate and reproducible size characterisation of
NPs dispersed in water-based solvents.
Materials and methods
Test materials
NIST traceable polystyrene nanospheres, nominally
100 and 200 nm (1 % solids), were purchased from
Thermo Fisher Scientific Inc., whilst gold NPs,
nominally 60 and 80 nm (0.01 % solids), were
purchased from BB International, Cardiff. Ham’s
F10 nutrient mix and Bovine Serum Albumin (BSA)
were purchased from Sigma Aldrich Co. HPLC grade
water was purchased from Rathburn Chemicals Ltd.,
Scotland. 0.02 lm Anotop 25 syringe filters (What-
man GmbH, Germany) were used to filter water and
BSA samples prior to analysis.
Samples preparation
Samples were aliquoted from a single lot prior to the
start of each round (either pre-diluted or neat),
ensuring all participating labs received aliquots of
the same materials. Rounds 1 and 2 were carried out on
the same four monodisperse samples, dispersed in
water, round 3 analysed three monodisperse samples,
again dispersed in water. Round 4 included a bimodal
Table 1 History of
development of NTA
software showing list of
parameters along with the
number of user adjustable
settings for each parameter
Part of analysis Year 2009 2010 2011 2012
NTA Version 2.0 2.1 2.2 2.3
Data collection Capture time 215 215 5 5
Shutter 1500 1500 1 1
Camera gain 680 680 16 16
Gamma 2 1 1 1
Data analysis Brightness 186 186 1 1
Image gain 1000 1000 1 1
Blur 5 4 1 1
Detection threshold 188 100 50 20
Max blob size 3000 1 1 1
Min track length 183 1 1 1
Min expected particle size 9 9 4 1
# Free user setting 11 8 4 3
# Variations 3.8 9 1023 1.5 9 1017 1.6 9 104 1.6 9 103
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sample, and monodisperse nanospheres dispersed in
biological media with and without the addition of
BSA. The details of the composition and characteris-
tics of the samples used in the present study are
summarised in Table 2.
All samples were distributed from NanoSight.
Samples for rounds 1 and 2 were prepared by
University College Dublin, samples for rounds 3 and
4 were prepared by NanoSight. Protocols were all
developed and distributed by NanoSight. Effort was
taken to ensure samples were always analysed blind by
participants, however, the solvent and the material
were known, for MSDSs to be distributed.
Participants and systems
Twelve Laboratories from Europe and the USA
participated in the four rounds of the ILC using
instruments from NanoSight Ltd., Amesbury, UK,
between September 2012 and April 2013 as per
manuscript authorship. Laboratories were each allo-
cated a unique participant number allowing results to
remain anonymous. The participants in this compari-
son were not pre-screened in any way, some users
having received no direct training on the system in their
laboratory. The key characteristics of the group were
that they were eager to ensure that they were using their
systems correctly and to acquire reproducible results.
Participants were given no additional training,
although where issues/outlying results were identified,
they were investigated thoroughly to establish the root
cause, the participants informed and the protocol
appropriately improved (where possible).
Details of the NanoSight platforms, laser wave-
lengths and camera type used by each laboratory are
given in Table 3. Laboratories reported results in the
form of summary files (output by NTA) for each sample.
Results were collated and analysed by NanoSight.
Protocol Development
Results were disseminated to all partners following
rounds 2, 3 and 4. This allowed discussion with
partners about how to proceed and allowed the group’s
Table 2 Characteristics of nanoparticle samples used in the study
Particle composition Source Round robin Nominal size (nm) Initial concentration
(% solids)
Diluent
Gold BBI 1 and 2 30 ± 2 (TEM) *0.01 H2O
Carboxylated
polystyrene
Invitrogen 1 and 2 100 ± 11 (TEM) *0.1 H2O
Aminated
polystyrene
Polysciences 1 and 2 100 *0.1 H2O
Silica Polysciences 1 and 2 100 *0.1 H2O
Polystyrene Thermo Scientific 3 102 ± 3 (TEM) *1 H2O
Gold BBI 3 60 ± 3 (TEM) *0.01 H2O
Gold BBI 3 81 ± 4 (TEM) *0.01 H2O
Polystyrene Thermo Scientific 4 102 ± 3 (TEM) *1 H2O, Ham’s F10
Nutrient Mix, BSA
Polystyrene Thermo Scientific 4 203 ± 5 (TEM) *1 H2O
Gold BBI 4 81 ± 4 (TEM) *0.01 H2O
Table 3 NanoSight systems used for ILC by participant
number
Lab
code
Platform Camera Laser
wavelength (nm)
Temperature
control
1 LM10 sCMOS 532 Yes
2 NS500 EMCCD 532 Yes
3 NS500 sCMOS 405 Yes
4 NS500 sCMOS 405 Yes
5 LM20 CCD 635 No
6 LM10 CCD 635 No
7 LM10 CCD 635 No
8 LM20 CCD 635 No
9 NS500 sCMOS 405 Yes
10 LM20 CCD 635 No
11 LM10 EMCCD 405 Yes
12 LM10 sCMOS 405 No
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expertise to be employed. Choice of samples for a
round was only made following the collection and
analysis of the results from the preceding round. This
allowed an assessment of the progress, the choice of
appropriate samples to challenge progress and time for
development/improvement of the protocol.
ILC round 1
A preliminary ILC (round 1) was performed on 4
samples (nominally gold 30 nm, 100 nm carboxylated
polystyrene, 100 nm aminated polystyrene and
100 nm silica), without any protocol provided. Par-
ticipants analysed the samples according to their own
‘in-house’ protocols for using NTA. This highlighted a
number of issues, such as the need to perform replicate
measurements on each sample and a need to ensure
sample dilution to an appropriate concentration for the
NTA system, which were incorporated into the
protocol for subsequent rounds.
ILC round 2
Round 2 analysed the same samples as round 1, but
under a protocol developed to standardise methods
between participating laboratories. The protocol
covered sample handling and storage, sample
preparation (standard dilutions for each sample),
video capture (60 s duration) and data analysis and
export. Each laboratory analysed each sample in
triplicate to allow statistical analysis under repeat-
ability conditions.
ILC round 3
The results and particle sizes from rounds 1 and 2
being known by the participants, three new samples
were supplied for analysis in round 3 (nominally
100 nm polystyrene, 60 nm gold and 80 nm gold),
along with an updated protocol, which was amended
in light of the results for round 2. Samples were
shipped with a temperature sensor which indicated if
the contents were exposed to temperatures below
4 C. Laboratories were also supplied with a range of
disposables, including 0.02 lm syringe filters and
HPLC grade water. Updates to the protocol included a
system recalibration step (if required), software
update to the newest version of NTA, vibration
checks (to prevent mis-sizing), and recording six
replicate videos for each sample to improve statistical
analysis.
ILC round 4
Unlike previous rounds, where all the samples were
monodisperse nanospheres diluted in water, round 4
investigated both a bimodal sample (80 nm gold and
200 nm polystyrene) and monodisperse nanospheres
(100 nm polystyrene) suspended in biological media
(Ham’s F10 nutrient mix) and biological media
supplemented with BSA (Ham’s F10 nutrient mix
plus 5 mg/ml BSA). This allowed analysis of samples
in more complex aqueous solutions than water.
Samples were shipped with two temperature sensors,
to indicate if the contents were exposed to tempera-
tures below 4 C or above 29 C.
Results and discussion
Laboratories submitted reports containing modal sizes for
each replicate of each sample run, along with the particle
size distributions, with outlying results being discarded
[consisting of 0 (of 48), 6 (of 48), 0 (of 36) and 3 (of 44)
from rounds 1, 2, 3 and 4, respectively]. During each of
the rounds where technical causes could be unambigu-
ously identified or it was ascertained that a participant
was not fully complying with the protocol, these results
were discarded. This was (usually) assumed to be a
weakness of the protocol, which was then modified to
better ensure compliance in future ILC rounds.
Method reproducibility analysis was carried out
using methods laid out in ISO 5725-2 (ISO 1994). The
modal sizes obtained for each sample from rounds 2, 3
and 4 were analysed using both classical [average and
standard deviation (SD) based] and robust [median
and median absolute deviation based (MAD)] statis-
tics as per ISO 5725-5 (ISO 1998). Robust statistics
has the advantage that it is much less sensitive to
outliers and so a median value better represents the
centre of a distribution of results reported from
different laboratories. In addition, the SD describing
a second order effect is considerable more sensitive
towards results that are further away from the mean
value, and are therefore potential outliers, than
towards all the results that are close to the mean
value. MAD, as median absolute deviation, is less
sensitive to large deviations at the extremes.
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Analysis of the results obtained from ILC round 1
shows the variation and lack of reproducibility of
results from the 12 laboratories when no protocol was
supplied. Figure 2 summarises the modal size results
obtained during ILC round 1 on 30 nm gold nano-
spheres based on standard (a) and robust (b) statistical
analysis. It appears clear from Fig. 2 that results from
2 of 12 laboratories do not match with the data of the
other 10 partners. Therefore, in the case of classic
statistical analysis the mean value is biased due to the
presence of these outlier results (Fig. 2a) whereas
most of the values are close to the median value. As
expected, this discrepancy between mean and median
values is considerably reduced by the robust statistical
data treatment, which is typically more appropriate for
such a study (Fig. 2b). The range of the 95 %
confidence interval is also smaller. This poor repro-
ducibility of an interlaboratory test, as indicated by a
coefficient of variation of 54.8 %, can easily be
attributed to the absence of guidance in the ILC round
1 which included users who had had no training (either
internal or external) in the technique or on their
system. The lack of an adequately defined measurand
in ILC round 1 resulted in an excessive uncertainty of
the measurement, as predicted by the guide to the
uncertainty in measurement (GUM) (JGCM 2008).
Between the last 3 rounds, the protocols were
upgraded on the basis of issues encountered in the
preceding round, covering all the aspects of the
experimental process: sample shipping (temperature
sensors), sample handling and preparation (e.g., dilu-
tion), sample storage, control of measurement param-
eters (e.g., video control, detection threshold), software
update (e.g., vibration check) and analytical data
treatment (e.g., number of replicates, statistic models).
The positive impacts that a well-established proto-
col and good compliance exert on the robustness of the
NP size determination with NTA technique is further
emphasised when we consider the calculated coeffi-
cient of variation as a comparative parameter between
the different ILC rounds. The percentage coefficients
of variation are summarised in Table 4 showing a
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Fig. 2 Modal particle size for 30 nm gold particles from ILC
round 1 showing results from each partner ordered by increasing
modal value based on a classical (±2 SD) and b robust (±2 MAD)
statistical analysis. The mean value (solid line), median (dashed
line) and 95 % confidence intervals (dotted line) are also shown
Table 4 Percentage coefficient of variation for each sample in
the ILC
ILC Round 1 (%
CV)
2 (%
CV)
3 (%
CV)
4 (%
CV)
30 nm gold 54.8 10.5
100 nm carboxylate
polystyrene
33.3 9.3
100 nm aminated polystyrene 31.2 15.9
100 nm silica 34.5 10.0
100 nm polystyrene 3.5 3.1
60 nm gold 5.1
80 nm gold 4.1
100 nm
polystyrene ? nutrient Mix
3.7
100 nm
polystyrene ? nutrient
mix ? BSA
4.7
80 nm gold (in bimodal
sample)
5.5
200 nm polystyrene (in
bimodal sample)
5.2
Average (% CV) 38.5 11.4 4.2 4.4
3.8a
a Considering only monodisperse samples
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clear link between the improving reproducibility of
measurements and successive rounds. The averaged
percentage coefficient of variation calculated for
monodisperse samples progressively decreases from
ILC round 1 to round 4: 38.5, 11.4, 4.2 and 3.8 %
(Fig. 3).
Once again, the combination of a powerful analyt-
ical technique with improved protocols gave rise to
robust and reproducible determination of the modal
size of both monodisperse and bimodal nanosphere
samples prepared in water and complex biological
matrices.
Standard and robust analyses were established
with participant results from all ILC rounds. In the
case of ILC round 4, the modal size results obtained
on a nominal 100 nm polystyrene nanospheres based
on classical and robust statistics are reported in
Fig. 4a and b, respectively. In that round, the results
obtained for 10 laboratories out of a total of 11 are
within the 95 % confidence interval and so match
with the mean and median values, for both classical
and robust statistical analyses. The range of the
95 % confidence interval is dramatically decreased
in comparison to the one obtained in ILC round 1.
As mentioned earlier, the very low coefficient of
variation calculated at ILC round 4 for monodis-
perse solution of polystyrene nanosphere (3.1 %)
strongly emphasises the effect of a well-established
SOP for highly reproducible and accurate NTA
measurements.
By ILC round 4, the averaged modal particle size
distribution resulting from the analysis of 11 labo-
ratories (one laboratory failed to supply data) on
monodisperse polystyrene nanospheres (100 nm)
diluted in water clearly demonstrates the analytical
reliability and power of the NTA technique, when
supported by a well-defined SOP, as shown in
Fig. 5. The average modal size and coefficient of
variation corresponding to this set of measurements
were calculated to be 101.7 nm and 3.12 %,
respectively. Similarly, during the same round
bimodal samples containing a mixture of nominally
80 nm gold (77–85 nm, TEM) and 200 nm polysty-
rene (203 ± 5 nm, TEM) nanospheres were also
analysed and the modal particle size distributions
obtained by 11 laboratories are depicted in Fig. 6. In
that case, the calculated average modal sizes were
0
10
20
30
40
RR1 RR2 RR3 RR4
Rounds
CV
 (%
)
Fig. 3 Evolution of the average percentage coefficient of
variation from ILC round 1 to ILC round 4. The percentage
coefficient of variation is shown to decrease with each round due
to improvements within the protocol
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Fig. 4 Modal particle size for 100 nm polystyrene particles
from ILC round 4, showing results from each partner ordered by
increasing modal value based on a classical (±2 SD) and
b robust (±2 MAD) statistical analysis. Mean (solid line),
median (dashed line) and 95 % confidence intervals (dotted
line) are also shown
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84.0 and 190.7 nm with corresponding coefficients
of variations of 5.47 and 5.16 %, respectively. Both
the relatively high NP size measurement accuracy
and reproducibility confirm that NTA technique is
also well adapted for the size analysis of bimodal
samples.
Conclusion and outlook
Overall, it is clear that in the absence of shared
guidelines on how to use a system and prepare
samples, variability across laboratories can be large
even for relatively monodispersed samples (ILC1).
The definition of a shared protocol allowed improved
results to be obtained (ILC2), however, the ILC
exercise clearly outlines that even a well-defined
protocol (much more complete and detailed than what
is usually described in the experimental section of
published work) can still lead to a (*4 % CV)
variability of outcomes. This has clear implications for
the on-going debate on the definition of guidelines for
reporting research in this field.
The ILC has shown that, with the guidance of a
well-written protocol, users of NTA (even those with
little or no training on the instrument) are able to
obtain reproducible and accurate modal particle size
results on a range of samples, both monodisperse and
bimodal, on samples dispersed in water or biological
media and on particles of different sizes and material
composition. It is important to note here that the
samples used in this study were all nominally
spherical.
This study has shown that a well-designed and
focused series of round robins can help identify
relevant issues that have a significant effect on
measurement results. It has been demonstrated to be
an effective way of improving the understanding of the
basics of measurement techniques such as NTA. This
leads to a better specification of the measurand, and
therefore to a more elaborate and more useful
protocol, detailing important steps in the measurement
procedure.
Future work will include additional rounds
involving more complex mixtures and matrices and
extension to other measurands that will help
improve understanding of the effect of additional
parameters that are relevant for these advanced
measurement scenarios. With this, the current per-
formance characteristics of NTA can be further
determined. This may initiate new developments that
remove the current limiting factors. All this would
not have been possible without a soundly designed
series of round robins. It is envisaged that the
challenges to be faced to achieve similar outcomes
for biological testing of NP–cell interactions could
be even greater, because of the complexity of living
organisms and difficulty in controlling such exper-
iments to this level.
Further steps could also be the direct comparison of
NTA measurements with other sizing techniques such
as measurements based on DLS, which is known to
have certain limitations, but is a more established
technique.
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Fig. 5 Averaged particle size distribution of nominally 100 nm
polystyrene nanospheres in water analysed by 11 laboratories in
ILC round 4. Size distribution ±1 SD is represented by the two
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nanospheres in water analysed by 11 laboratories in ILC round 4
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